You are here

  • Home
  • Archive
  • Volume 76, Issue 9
  • Response to: ‘Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease’ by Orlando et al

Article metrics

Article menu

Download PDFPDF

Correspondence response
Response to: ‘Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease’ by Orlando et al
Free

 

Online download statistics by month:

Online download statistics by month: February 2017 to March 2024

AbstractFullPdf
Feb 201717084
Mar 2017215559
Apr 201705719
May 201715211
Jun 201754013
Jul 201728298
Aug 201723223344
Sep 2017828225
Oct 2017686916
Nov 2017343412
Dec 2017474912
Jan 2018393610
Feb 2018484810
Mar 2018424016
Apr 201845458
May 201835364
Jun 201836369
Jul 201826262
Aug 201831319
Sep 201833337
Oct 201814141
Nov 201813132
Dec 201819194
Jan 2019882
Feb 2019242610
Mar 201927279
Apr 201916167
May 201924247
Jun 2019191913
Jul 201924246
Aug 201915156
Sep 201916164
Oct 201923214
Nov 2019191914
Dec 201916166
Jan 202026268
Feb 2020994
Mar 2020776
Apr 2020772
May 202013134
Jun 2020151410
Jul 202016165
Aug 2020773
Sep 202018181
Oct 202039396
Nov 202010104
Dec 202017155
Jan 202110107
Feb 2021998
Mar 2021997
Apr 2021443
May 202112124
Jun 2021775
Jul 2021994
Aug 2021113
Sep 2021885
Oct 20216516
Nov 20216516
Dec 202116165
Jan 2022774
Feb 2022994
Mar 202214143
Apr 2022882
May 2022252515
Jun 202220207
Jul 202219195
Aug 202224248
Sep 2022373712
Oct 202226266
Nov 2022131315
Dec 202210102
Jan 2023432
Feb 202310102
Mar 202311113
Apr 20232212
May 2023556
Jun 2023441
Jul 2023448
Aug 2023554
Sep 2023443
Oct 2023881
Nov 2023992
Dec 202312124
Jan 202415155
Feb 2024446
Mar 202488108
Total17102070864